Sponsors

Human papillomavirus vaccination

Analysis indicates that rates of high-grade cervical lesions decreased in young US women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations.

CDC/Judy Schmidt; James Gathany

Published in the journal Cancer, the study illustrates some of the challenges in monitoring a vaccine’s impact during a time of concurrent changes in screening. More than half of high-grade cervical lesions that can lead to cancer are caused by persistent HPV infection that can be prevented if a person receives an HPV vaccine. Monitoring trends in the incidence of these lesions is helpful for evaluating the impact of HPV vaccination.

Latest Issues

ECP 2026 - 38th European Congress of Pathology

Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026

UK NEQAS Parasitology Symposium

UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026

UKHSA Conference 2026

Manchester Central, Manchester, M2 3GX
22-23 September, 2026

Cardiac Marker Dialogues

Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026

46th European Congress of Cytology

Hilton Antwerp Old Town, Antwerp
4-7 October, 2026